A bill for an act relating to prescription drug affordability, including the creation of a prescription drug affordability board.

SF 264 creates a Prescription Drug Affordability Board in Iowa to address high prescription drug costs. The board, appointed by the governor with Senate confirmation, will review drug pricing and may recommend upper payment limits for prescription drugs affecting all Iowans, especially patients with illnesses, opioid crisis communities, and healthcare providers. Key provisions require the board to hold public meetings, accept public input, and enforce strict conflict-of-interest rules (e.g., members cannot receive over $5,000 annually from drug manufacturers). The bill establishes this mechanism to review drug costs but does not yet implement price controls.